Letter from the Editor in Chief

DOI: 10.19102/icrm.2016.070308

MOUSSA MANSOUR, MD, FHRS, FACC

Syndrome of Supine Hypertension with Orthostatic Hypotension. A Nightmare for Physicians

DOI: 10.19102/icrm.2016.070304

AAMIR AHMED, BS¹, BLAIR GRUBB, MD, FACC², LIAQAT ZAMAN, MD, FACC, FHRS¹ and KHALIL KANJWAL, MD, FACC, FHRS, CCDS¹

¹Michigan Cardiovascular Institute, Central Michigan University, Saginaw, MI

²Division of Cardiology, Department of Medicine, The University of Toledo Medical Center, OH

Utilizing 3D NavX for Transseptal Puncture as an Additional Safeguard: A Case Series

DOI: 10.19102/icrm.2016.070301

CAITLIN KNOEDEL, BS¹, BENJAMIN C DEXTER, MD¹, JENNIFER R LAMPE, RRT¹, IAN H LAW, MD¹, NICHOLAS H VON BERGEN, MD²

¹ The University of Iowa Children’s Hospital, Iowa City, IA
² The University of Wisconsin – Madison, Madison, WI

Inappropriate Shocks within 24 hours after Implantation of a Subcutaneous Defibrillator with a Two-incision Technique

DOI: 10.19102/icrm.2016.070302

JASON S. CHINITZ, MD, PATRICIA NADRAUS, MSN, RN, ALICIA DARGE, PAC, JEAN CACCIABAUDO, MD and ERIK J. ALTMAN, MD, MBA

Southside Hospital, Northwell Health Physician Partners, Hofstra Northwell School of Medicine, Bayshore, NY

Appetite Suppressant-induced Propafenone Proarrhythmia

DOI: 10.19102/icrm.2016.070303

TYLER THERIOT, BA¹, J. DAVID THERIOT, APRN¹ and RICHARD ABBEN, MD^1,2

¹Arrhythmia Service, Cardiovascular Institute of the South, Houma, LA

²Cardiac Electrophysiology Section, LSU School of Medicine, New Orleans, LA

Remote Magnetic Navigation-guided Catheter Ablation of Atrioventricular Nodal Reentrant Tachycardia in an Adult Patient with Prior Surgical Closure of Perimembranous Ventricular Septal Defect during Infancy

DOI: 10.19102/icrm.2016.070305

STEFANI M. SAMPLES, MD¹ and ADAM E. BERMAN, MD, FHRS²

¹Department of Pediatric Cardiology, Augusta University, Children’s Hospital of Georgia, Augusta, GA

²Director of Cardiac Arrhythmia Ablation Services, AU Health Heart and Cardiovascular Services, Augusta, GA

Ineffective Shock Therapy in a Subcutaneous Implantable Cardioverter-Defibrillator Patient with Hypertrophic Cardiomyopathy

DOI: 10.19102/icrm.2016.070306

BUNNY SABERWAL, MRCP, AUROJIT ROY, MBBS and PIER D. LAMBIASE, PhD, FRCP

Barts Heart Centre, West Smithfield, London, UK.

Interview with Luigi Di Biase, MD, PhD, FACC, FHRS

DOI: 10.19102/icrm.2016.070307

ANGELINA WAGNER